Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Israel who wrote (14749)	4/21/1999 9:36:00 AM
From: Due Diligence	Respond to of 25711

PHLB news: (COMTEX) B: Pharmaceutical Laboratories Introduces Referral Marketing B: Pharmaceutical Laboratories Introduces Referral Marketing CORPUS CHRISTI, TEXAS (April 21) BW HEALTHWIRE -April 21, 1999-- -- Liquid Solutions(r) Referral Centers Expected to Increase Sales on a Profitable Basis -- Pharmaceutical Laboratories, Inc. (OTC BB:PHLB), a leader in nutriceuticals with advanced liquid nutritional products, today announced that it is launching a Liquid Solutions(r) Referral Center program in several cities this May. The Company plans to establish both company and independently owned Liquid Solutions Referral Centers. In creating this nationwide network, PHLB reported that it is targeting all markets from small rural towns to major urban centers in each geographic region. The Company also noted that it is currently reviewing numerous applications from several states. "The referral center program combines traditional marketing with the best aspects of direct sales and network marketing," stated Company President and CEO Jerry McClure. "The concept is simple but powerful in that healthcare professionals, businesses, individuals, and fundraising organizations can earn significant money by simply referring people to one of our Liquid Solutions Referral Centers where they will find a reliable source of nutritional information as well as the best liquid vitamins, minerals, herbals, and aloe vera skin care products at great prices." The Company's referral center program enables healthcare professionals, businesses, individuals, and fundraising organizations to receive 20 percent of all purchases made by the referred members on an ongoing basis. This provides a continuous source of income for the referring individual or organization without the need to sell products. "Having been in the nutritional products industry for more than a decade," McClure continued, "PHLB has maintained its position as the leader in liquid nutritional technology through advertising, relationships with leading retail stores, and a solid reputation for quality liquid solutions. Recent trends in the $9.8 billion nutritional products industry require us to supplement our efforts with innovative and proactive marketing. In order to maintain positive bottom line results, we are designing these campaigns to require relatively low capital infusions, thus enabling the Company to increase sales on a profitable basis." Individuals interested in owning or operating a referral center should call 800-856-7040 for more information. Pharmaceutical Laboratories, Inc. specializes in the development, manufacturing, and marketing of liquid vitamin and nutritional products in the U.S. and abroad. The Company's products are manufactured at its on-site production facilities under strict quality standards, with each batch tested for potency, purity, and stability to guarantee the accuracy of its label claims. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. For further information, see www.otcfn.com/phlb and www.phlb.com. -0- sb/bos* CONTACT: OTC Financial Network Mario "Ike" Iacoviello, Investor Relations 800-863-1431/760-931-9211 ike@otcfn.com or Pharmaceutical Laboratories George Baucom, CFO & Dir. of IR 800-856-7040 george@phlb.com KEYWORD: TEXAS INDUSTRY KEYWORD: PHARMACEUTICAL MEDICINE Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *